1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4.
Voice of Customer
5. Clinical Trial
Analysis
5.1. Ongoing Clinical
Trials
5.2. Completed Clinical
Trials
5.3. Terminated Clinical
Trials
5.4. Breakdown of
Pipeline, By Development Phase
5.5. Breakdown of Pipeline,
By Status
5.6. Breakdown of
Pipeline, By Study Type
5.7. Breakdown of
Pipeline, By Country
5.8. Clinical Trials Heat
Map
6.
Global Antimalarial Drugs Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value & Volume
6.2.
Market Share & Forecast
6.2.1. By Drug Type
(Quinine, Chloroquine, Proguanil, Amodiaquine, Mefloquine, Hydroxychloroquine,
Pyrimethamine, Others)
6.2.2. By Drug Class (Aryl
Aminoalcohol Compounds, Antifolate Compounds, Artemisinin Compounds,
Antimicrobials)
6.2.3. By Route of
Administration (Oral, Powder Inhalation, Intravenous Administration)
6.2.4. By Malaria Type
(Plasmodium Falciparum, Plasmodium Malariae, Plasmodium Vivax, Plasmodium
Ovale, Plasmodium Knowlesi)
6.2.5. By Application
(Prevention, Treatment of Malaria)
6.2.6. By Distribution
Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce, Others)
6.2.7. By Company (2022)
6.2.8. By
Region
6.3. Product
Market Map
7.
Asia-Pacific Antimalarial Drugs Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value & Volume
7.2.
Market Share & Forecast
7.2.1. By Drug Type
7.2.2. By Drug Class
7.2.3. By Route of
Administration
7.2.4. By Malaria Type
7.2.5. By Application
7.2.6. By Distribution
Channel
7.2.7.
By Country
7.3.
Asia-Pacific: Country Analysis
7.3.1.
China Antimalarial Drugs Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value & Volume
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Drug Type
7.3.1.2.2.
By Drug Class
7.3.1.2.3.
By Route of Administration
7.3.1.2.4.
By Malaria Type
7.3.1.2.5.
By Application
7.3.1.2.6.
By Distribution Channel
7.3.2.
India Antimalarial Drugs Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value & Volume
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Drug Type
7.3.2.2.2.
By Drug Class
7.3.2.2.3.
By Route of Administration
7.3.2.2.4.
By Malaria Type
7.3.2.2.5.
By Application
7.3.2.2.6.
By Distribution Channel
7.3.3.
Japan Antimalarial Drugs Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value & Volume
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Drug Type
7.3.3.2.2.
By Drug Class
7.3.3.2.3.
By Route of Administration
7.3.3.2.4.
By Malaria Type
7.3.3.2.5.
By Application
7.3.3.2.6.
By Distribution Channel
7.3.4.
South Korea Antimalarial Drugs Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value & Volume
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Drug Type
7.3.4.2.2.
By Drug Class
7.3.4.2.3.
By Route of Administration
7.3.4.2.4.
By Malaria Type
7.3.4.2.5.
By Application
7.3.4.2.6.
By Distribution Channel
7.3.5.
Singapore Antimalarial Drugs Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value & Volume
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Drug Type
7.3.5.2.2.
By Drug Class
7.3.5.2.3.
By Route of Administration
7.3.5.2.4.
By Malaria Type
7.3.5.2.5.
By Application
7.3.5.2.6.
By Distribution Channel
7.3.6.
Australia Antimalarial Drugs Market Outlook
7.3.6.1.
Market Size & Forecast
7.3.6.1.1.
By Value & Volume
7.3.6.2.
Market Share & Forecast
7.3.6.2.1.
By Drug Type
7.3.6.2.2.
By Drug Class
7.3.6.2.3.
By Route of Administration
7.3.6.2.4.
By Malaria Type
7.3.6.2.5.
By Application
7.3.6.2.6.
By Distribution Channel
8.
Europe Antimalarial Drugs Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value & Volume
8.2.
Market Share & Forecast
8.2.1. By Drug Type
8.2.2. By Drug Class
8.2.3. By Route of
Administration
8.2.4. By Malaria Type
8.2.5. By Application
8.2.6. By Distribution
Channel
8.2.7.
By Country
8.3.
Europe: Country Analysis
8.3.1.
France Antimalarial Drugs Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value & Volume
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Drug Type
8.3.1.2.2.
By Drug Class
8.3.1.2.3.
By Route of Administration
8.3.1.2.4.
By Malaria Type
8.3.1.2.5.
By Application
8.3.1.2.6.
By Distribution Channel
8.3.2.
Germany Antimalarial Drugs Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value & Volume
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Drug Type
8.3.2.2.2.
By Drug Class
8.3.2.2.3.
By Route of Administration
8.3.2.2.4.
By Malaria Type
8.3.2.2.5.
By Application
8.3.2.2.6.
By Distribution Channel
8.3.3.
United Kingdom Antimalarial Drugs Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value & Volume
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Drug Type
8.3.3.2.2.
By Drug Class
8.3.3.2.3.
By Route of Administration
8.3.3.2.4.
By Malaria Type
8.3.3.2.5.
By Application
8.3.3.2.6.
By Distribution Channel
8.3.4.
Italy Antimalarial Drugs Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value & Volume